SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-017556
Filing Date
2021-03-24
Accepted
2021-03-24 17:30:23
Documents
67
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2020_relmadatherapeutic.htm 10-K 995416
2 RELMADA THERAPEUTICS, INC., 2021 EQUITY INCENTIVE PLAN f10k2020ex10-61_relmada.htm EX-10.61 168600
3 CONSENT OF MARCUM LLP f10k2020ex23-1_relmada.htm EX-23.1 2970
4 CERTIFICATION f10k2020ex31-1_relmada.htm EX-31.1 7699
5 CERTIFICATION f10k2020ex31-2_relmada.htm EX-31.2 7764
6 CERTIFICATION f10k2020ex32-1_relmada.htm EX-32.1 3434
7 CERTIFICATION f10k2020ex32-2_relmada.htm EX-32.2 3356
  Complete submission text file 0001213900-21-017556.txt   4864662

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE rlmd-20201231.xml EX-101.INS 732631
9 XBRL SCHEMA FILE rlmd-20201231.xsd EX-101.SCH 61481
10 XBRL CALCULATION FILE rlmd-20201231_cal.xml EX-101.CAL 28140
11 XBRL DEFINITION FILE rlmd-20201231_def.xml EX-101.DEF 251831
12 XBRL LABEL FILE rlmd-20201231_lab.xml EX-101.LAB 501927
13 XBRL PRESENTATION FILE rlmd-20201231_pre.xml EX-101.PRE 264203
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39082 | Film No.: 21769312
SIC: 2834 Pharmaceutical Preparations